Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda.
HIV prevention
HIV vaccine studies
Uganda
high-risk
loss to follow up
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
24 05 2022
24 05 2022
Historique:
received:
29
03
2022
revised:
15
05
2022
accepted:
17
05
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
High participant retention is essential to achieve adequate statistical power for clinical trials. We assessed participant retention and predictors of loss to follow-up (LTFU) in an HIV vaccine-preparedness study in Masaka, Uganda. Between July 2018 and March 2021, HIV sero-negative adults (18-45 years) at high risk of HIV infection were identified through HIV counselling and testing (HCT) from sex-work hotspots along the trans-African highway and fishing communities along the shores of Lake Victoria. Study procedures included collection of baseline socio-demographic data, quarterly HCT, and 6-monthly collection of sexual risk behaviour data. Retention strategies included collection of detailed locator data, short clinic visits (1-2 h), flexible reimbursement for transport costs, immediate (≤7 days) follow-up of missed visits via phone and/or home visits, and community engagement meetings. LTFU was defined as missing ≥2 sequential study visits. Poisson regression models were used to identify baseline factors associated with LTFU. 672 participants were included in this analysis. Of these, 336 (50%) were female and 390 (58%) were ≤24 years. The median follow-up time was 11 months (range: 0-31 months). A total 214 (32%) participants were LTFU over 607.8 person-years of observation (PYO), a rate of 35.2/100 PYO. LTFU was higher in younger participants (18-24 years versus 35-45 years, adjusted rate ratio (aRR) = 1.29, 95% confidence interval (CI) 0.80-2.11), although this difference was not significant. Female sex (aRR = 2.07, 95% CI, 1.51-2.84), and recreational drug use (aRR = 1.61, 95% CI, 1.12-2.34) were significantly associated with increased LTFU. Engagement in transactional sex was associated with increased LTFU (aRR = 1.36, 95% CI, 0.97-1.90) but this difference was not significant. LTFU was higher in 2020-2021 (the period of COVID-19 restrictions) compared to 2018-2019 (aRR = 1.54, 1.17-2.03). Being Muslim or other (aRR = 0.68, 95% CI 0.47-0.97) and self-identification as a sex worker (aRR = 0.47, 95% CI, 0.31-0.72) were associated with reduced LTFU. We observed a high LTFU rate in this cohort. LTFU was highest among women, younger persons, recreational drug users, and persons who engage in transactional sex. Efforts to design retention strategies should focus on these subpopulations.
Sections du résumé
BACKGROUND
High participant retention is essential to achieve adequate statistical power for clinical trials. We assessed participant retention and predictors of loss to follow-up (LTFU) in an HIV vaccine-preparedness study in Masaka, Uganda.
METHODS
Between July 2018 and March 2021, HIV sero-negative adults (18-45 years) at high risk of HIV infection were identified through HIV counselling and testing (HCT) from sex-work hotspots along the trans-African highway and fishing communities along the shores of Lake Victoria. Study procedures included collection of baseline socio-demographic data, quarterly HCT, and 6-monthly collection of sexual risk behaviour data. Retention strategies included collection of detailed locator data, short clinic visits (1-2 h), flexible reimbursement for transport costs, immediate (≤7 days) follow-up of missed visits via phone and/or home visits, and community engagement meetings. LTFU was defined as missing ≥2 sequential study visits. Poisson regression models were used to identify baseline factors associated with LTFU.
RESULTS
672 participants were included in this analysis. Of these, 336 (50%) were female and 390 (58%) were ≤24 years. The median follow-up time was 11 months (range: 0-31 months). A total 214 (32%) participants were LTFU over 607.8 person-years of observation (PYO), a rate of 35.2/100 PYO. LTFU was higher in younger participants (18-24 years versus 35-45 years, adjusted rate ratio (aRR) = 1.29, 95% confidence interval (CI) 0.80-2.11), although this difference was not significant. Female sex (aRR = 2.07, 95% CI, 1.51-2.84), and recreational drug use (aRR = 1.61, 95% CI, 1.12-2.34) were significantly associated with increased LTFU. Engagement in transactional sex was associated with increased LTFU (aRR = 1.36, 95% CI, 0.97-1.90) but this difference was not significant. LTFU was higher in 2020-2021 (the period of COVID-19 restrictions) compared to 2018-2019 (aRR = 1.54, 1.17-2.03). Being Muslim or other (aRR = 0.68, 95% CI 0.47-0.97) and self-identification as a sex worker (aRR = 0.47, 95% CI, 0.31-0.72) were associated with reduced LTFU.
CONCLUSION
We observed a high LTFU rate in this cohort. LTFU was highest among women, younger persons, recreational drug users, and persons who engage in transactional sex. Efforts to design retention strategies should focus on these subpopulations.
Identifiants
pubmed: 35681962
pii: ijerph19116377
doi: 10.3390/ijerph19116377
pmc: PMC9180097
pii:
doi:
Substances chimiques
AIDS Vaccines
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):517-21
pubmed: 11981369
BMC Public Health. 2014 Sep 22;14:986
pubmed: 25242015
BMC Res Notes. 2015 Dec 24;8:815
pubmed: 26703879
Medicine (Baltimore). 2021 Nov 5;100(44):e27719
pubmed: 34871265
Afr J AIDS Res. 2021 Mar;20(1):53-60
pubmed: 33632073
Trop Med Int Health. 2009 Feb;14(2):196-203
pubmed: 19207177
Sex Health. 2018 Nov;15(6):522-527
pubmed: 30476461
AIDS Behav. 2014 Jul;18(7):1199-223
pubmed: 24563115
BMC Med Res Methodol. 2020 Feb 12;20(1):32
pubmed: 32050900
Cult Health Sex. 2021 Jan;23(1):19-36
pubmed: 31702445
AIDS. 1997 Dec;11 Suppl 2:S13-9
pubmed: 9475707
PLoS One. 2020 Aug 24;15(8):e0238028
pubmed: 32834018
PLoS One. 2011;6(6):e20684
pubmed: 21677779
PLoS One. 2019 Jan 14;14(1):e0198460
pubmed: 30640918
J Adolesc Health. 2008 Jul;43(1):8-14
pubmed: 18565432
Cult Health Sex. 2011 May;13(5):575-88
pubmed: 21452092
J Int AIDS Soc. 2019 Apr;22(4):e25276
pubmed: 31037845
PLoS One. 2011;6(8):e24037
pubmed: 21909379